Smart investors chasing the AI boom tend to fixate on chips – but the real money is increasingly being made in what holds those chips together. That''s where things get interesting for Intel (INTC).

NVIDIA (NVDA) closed Monday at $216.61, up 4% on volume of 184.7 million shares. That is above the company's previous 52-week high of $212.19, making today the first time NVDA has traded at record ...

The Trump administration is injecting $1.6 billion into USA Rare Earth ( USAR), an Oklahoma-based miner, securing roughly a 10% stake in the company. This includes $277 million in equity for 16.1 ...

Over six decades at the helm of Berkshire Hathaway ( BRK-A, BRK-B), Warren Buffett transformed a struggling textile company into a conglomerate worth hundreds of billions. From 1965 until his ...

Wall Street analysts are now picking up what we’ve been telling you for more than six months, AI has a problem that needs a fix! AI takes massive amounts of energy to do even the simplest of tasks.

In recent years, the growing influence of big money in politics has raised alarms with the American people. This central theme of the 2016 election echoes another U.S. presidential contest, exactly ...

Silver is poised for a breakout, with prices climbing 22% year-to-date to $36.35 per ounce, driven by robust industrial demand and the metal's safe-haven appeal. Industrial applications, particularly ...

Marvell Technology ( MRVL), long seen as a solid but under-the-radar player in the AI chip race, just made its boldest move yet. Yesterday, the company announced it is buying Celestial AI, a ...

Nvidia ( NVDA) has ridden the AI wave to stratospheric heights, with shares surging over 1,000% over the last three years to a $4.3 trillion valuation. Fueled by insatiable demand for its GPUs ...

Stanley Druckenmiller is a Wall Street legend, renowned for his macro trading prowess. He managed money for George Soros, famously helping "break the Bank of England" in 1992 by shorting the British ...

Hims & Hers Health ( HIMS) launched a compounded semaglutide pill on Feb. 5 priced at an introductory $49 per month as an affordable alternative to Novo Nordisk’s ( NVO) Wegovy pill, quickly drawing ...

Market jitters over the sustainability of AI demand and a broader rotation out of high-flying tech stocks have eclipsed Advanced Micro Devices' ( AMD) stellar fourth-quarter earnings. Despite posting ...